Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
8 studies found for:    parkinson's a2a
Show Display Options
Rank Status Study
1 Recruiting Evaluation of [123I]MNI-420 and SPECT as a Marker of the Adenosine A2a Receptor in PD, HD and Healthy Subjects.
Conditions: Parkinson Disease;   Huntington Disease
Intervention: Drug: [123I]MNI-420
2 Completed A Study in Healthy Male Volunteers to Investigate a New Drug for the Treatment of Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: V81444
3 Completed KW-6002 to Treat Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: KW-6002;   Drug: IV Levodopa
4 Completed Study to Evaluate SYN115 in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Placebo;   Drug: Tozadenant
5 Completed
Has Results
A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (P04938)
Condition: Parkinson Disease
Interventions: Drug: Preladenant 2 mg tablet;   Drug: Preladenant 5 mg tablet;   Drug: Preladenant 10 mg tablet;   Drug: Placebo to Preladenant Tablet;   Drug: Rasagiline 1 mg capsule;   Drug: Placebo to Rasagiline capsule
6 Terminated
Has Results
A Placebo- and Active-Controlled Study of Preladenant in Early Parkinson's Disease (PD) (P05664)
Condition: Parkinson Disease
Interventions: Drug: Preladenant 2 mg tablet;   Drug: Preladenant 5 mg tablet;   Drug: Preladenant 10 mg tablet;   Drug: Rasagiline 1 mg capsule;   Drug: Placebo for Rasagiline 1 mg capsule;   Drug: Placebo for Preladenant
7 Completed Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF -509 (80 mg, 160 mg and 240 mg) "After Multiple Oral Doses" in Healthy Volunteers
Condition: Parkinson Disease
Interventions: Drug: PBF-509;   Drug: Placebo
8 Completed Study To Assess the Safety and Tolerability of PBF-509 in Male Healthy Volunteers
Condition: Parkinson Disease
Interventions: Drug: PBF-509;   Drug: Placebo

Indicates status has not been verified in more than two years